Deutsche Bank AG set a €60.00 ($70.59) price objective on Compugroup Medical SE (ETR:COP) in a research note published on Thursday. The brokerage currently has a buy rating on the stock.

A number of other research analysts have also recently weighed in on the stock. Berenberg Bank set a €53.00 ($62.35) price objective on shares of Compugroup Medical SE and gave the company a neutral rating in a research report on Friday, August 4th. Warburg Research set a €52.00 ($61.18) target price on shares of Compugroup Medical SE and gave the stock a neutral rating in a report on Thursday, August 3rd. Baader Bank set a €52.00 ($61.18) target price on shares of Compugroup Medical SE and gave the stock a buy rating in a report on Thursday, August 3rd. Finally, HSBC Holdings plc set a €60.00 ($70.59) target price on shares of Compugroup Medical SE and gave the stock a buy rating in a report on Wednesday, July 5th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of Buy and an average target price of €55.40 ($65.18).

Shares of Compugroup Medical SE (COP) traded down 0.800% on Thursday, reaching €48.972. 540 shares of the company were exchanged. The firm has a 50 day moving average price of €49.73 and a 200-day moving average price of €45.61. The stock has a market capitalization of €2.44 billion and a PE ratio of 53.521. Compugroup Medical SE has a 12-month low of €36.21 and a 12-month high of €52.80.

ILLEGAL ACTIVITY NOTICE: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/08/25/compugroup-medical-se-cop-given-a-60-00-price-target-at-deutsche-bank-ag.html.

Compugroup Medical SE Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physicianÂ’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical SE (ETR:COP)

Receive News & Stock Ratings for Compugroup Medical SE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical SE and related stocks with our FREE daily email newsletter.